DURHAM, NC—May 15, 2017— Clinical research and health technology company SignalPath today announced that Noelle Gaskill has joined as Vice President of Research Operations. At SignalPath, Gaskill will lead the delivery of offerings for site networks and those conducting clinical trials, overseeing the delivery of key services.
Gaskill joins after seven years in various roles at US Oncology Research, most recently as senior director of Research Operations. Gaskill was responsible for driving growth in the contract research operations and site management organization business lines, overseeing a team of more than 70 people. From her early career as a coordinator at a site in Houston to her leadership role at US Oncology, she has shown herself to be a thought leader in the conduct of research.
“Noelle brings expertise in managing large-scale clinical trial operations, both at a site level and across networks of sites,” said Dr. Brad Hirsch, SignalPath CEO. “She understands the pain points in the research process and has extensive experience solving for them. She is a critical addition to our leadership team and will be integral as we continue to support larger site networks and research operations at scale.”
Prior to US Oncology, she was a research administrator at Texas Children’s Cancer Center and for an NIH designated center. Gaskill has worked as a coordinator for pediatric trials and in cardiovascular device research. Gaskill holds a bachelor’s degree from Texas A&M University and a master’s of business administration from Texas Woman’s University.
SignalPath is a healthcare technology company focused on delivering solutions that accelerate and optimize the clinical research process. SignalPath offers a site- focused platform to streamline the operational workflow and financial management of clinical research, reducing the administrative burden on sites and empowering study teams to spend more time with patients. SignalPath additionally offers site management organizations and contract research organizations tooling to facilitate and optimize clinical trial operations across site networks. Learn more at www.SignalPath.com.